P
Precipio, Inc. (PRPO)
NCM – Real Time Price. Currency in USD
28.68
+0.21 (0.76%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
28.68
+0.21 (0.76%)
At close: May 12, 2026, 4:00 PM EDT
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
| Name | Position |
|---|---|
| Dr. Ayman A. Mohamed M.D. | Chief Technology Officer |
| Mr. Ahmed Zaki Sabet | Chief Operating Officer |
| Mr. Ilan Danieli | Founder, President, CEO & Director |
| Mr. Matthew Gage | Chief Financial Officer |
| Ms. Miri Chiko-Radomski | Chief Legal Counsel & People Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-06 | 8-K | tm2613783d1_8k.htm |
| 2026-04-28 | DEFA14A | ny20068819x2_defa14a.htm |
| 2026-04-28 | ARS | ny20068819x3_ars.pdf |
| 2026-03-30 | 10-K | prpo-20251231x10k.htm |
| 2026-02-27 | 8-K | tm267591d1_8k.htm |
| 2026-01-26 | S-8 | tm264098d1_s8.htm |
| 2025-12-29 | 8-K | tm2534444d1_8k.htm |
| 2025-11-14 | 10-Q | prpo-20250930x10q.htm |
| 2025-11-06 | 8-K | tm2530457d1_8k.htm |
| 2025-09-03 | 8-K | tm2525140d1_8k.htm |